These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8969696)

  • 1. Ribavirin for RSV lower respiratory tract infection.
    Zamorski M
    J Fam Pract; 1996 Dec; 43(6):536-7. PubMed ID: 8969696
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory tract infections caused by respiratory syncytial virus in children. Diagnosis and treatment.
    Van Woensel JB; Kimpen JL; Brand PL
    Minerva Pediatr; 2001 Apr; 53(2):99-106. PubMed ID: 11404731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful systemic high-dose ribavirin treatment of respiratory syncytial virus-induced infections occurring pre-engraftment in allogeneic hematopoietic stem cell transplant recipients.
    Gueller S; Duenzinger U; Wolf T; Ajib S; Mousset S; Berger A; Martin H; Serve H; Bug G
    Transpl Infect Dis; 2013 Aug; 15(4):435-40. PubMed ID: 23692664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1996 Jan; 97(1):137-40. PubMed ID: 8545210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of ribavirin in the treatment of RSV.
    Cooper KE
    Pediatr Nurs; 2001; 27(1):95-8. PubMed ID: 12025158
    [No Abstract]   [Full Text] [Related]  

  • 7. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children.
    Ventre K; Randolph A
    Cochrane Database Syst Rev; 2004 Oct; (4):CD000181. PubMed ID: 15494991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin for respiratory syncytial virus lower respiratory tract infection. A systematic overview.
    Randolph AG; Wang EE
    Arch Pediatr Adolesc Med; 1996 Sep; 150(9):942-7. PubMed ID: 8790125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus infections: characteristics and treatment.
    Chidgey SM; Broadley KJ
    J Pharm Pharmacol; 2005 Nov; 57(11):1371-81. PubMed ID: 16259768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection.
    Azzi JM; Kyvernitakis A; Shah DP; El Haddad L; Mahajan SN; Ghantoji SS; Heredia-Ariza E; Chemaly RF
    J Antimicrob Chemother; 2018 Nov; 73(11):3162-3169. PubMed ID: 30113677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children.
    Ventre K; Randolph AG
    Cochrane Database Syst Rev; 2007 Jan; (1):CD000181. PubMed ID: 17253446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory syncytial virus infection in adult BMT recipients: effective therapy with short duration nebulised ribavirin.
    McColl MD; Corser RB; Bremner J; Chopra R
    Bone Marrow Transplant; 1998 Feb; 21(4):423-5. PubMed ID: 9509980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation.
    Glanville AR; Scott AI; Morton JM; Aboyoun CL; Plit ML; Carter IW; Malouf MA
    J Heart Lung Transplant; 2005 Dec; 24(12):2114-9. PubMed ID: 16364859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribavirin for respiratory syncytial virus bronchiolitis reduced the risk of asthma and allergen sensitization.
    Chen CH; Lin YT; Yang YH; Wang LC; Lee JH; Kao CL; Chiang BL
    Pediatr Allergy Immunol; 2008 Mar; 19(2):166-72. PubMed ID: 18257904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of interobserver reliability in clinical assessment of RSV lower respiratory illness: a Pediatric Investigators Collaborative Network for Infections in Canada (PICNIC) study.
    Wang EE; Law BJ; Stephens D; Langley JM; MacDonald NE; Robinson JL; Dobson S; McDonald J; Boucher FD; de Carvalho V; Mitchell I
    Pediatr Pulmonol; 1996 Jul; 22(1):23-7. PubMed ID: 8856800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with death in patients with severe respiratory syncytial virus infection.
    Lee YI; Peng CC; Chiu NC; Huang DT; Huang FY; Chi H
    J Microbiol Immunol Infect; 2016 Oct; 49(5):737-742. PubMed ID: 25442868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature.
    Khanna N; Widmer AF; Decker M; Steffen I; Halter J; Heim D; Weisser M; Gratwohl A; Fluckiger U; Hirsch HH
    Clin Infect Dis; 2008 Feb; 46(3):402-12. PubMed ID: 18181739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Respiratory syncytial virus infection in adults.
    Murata Y; Falsey AR
    Antivir Ther; 2007; 12(4 Pt B):659-70. PubMed ID: 17944273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory syncytial virus infection in adults.
    Falsey AR
    Semin Respir Crit Care Med; 2007 Apr; 28(2):171-81. PubMed ID: 17458771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WITHDRAWN: Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children.
    Ventre K; Randolph A
    Cochrane Database Syst Rev; 2010 May; 2010(5):CD000181. PubMed ID: 20464715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.